These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 20347606)

  • 1. Insulin-like growth factors I and II receptors in the breast cancer survival disparity among African-American women.
    Kalla Singh S; Tan QW; Brito C; De León M; De León D
    Growth Horm IGF Res; 2010 Jun; 20(3):245-54. PubMed ID: 20347606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential insulin-like growth factor II (IGF-II) expression: A potential role for breast cancer survival disparity.
    Kalla Singh S; Tan QW; Brito C; De León M; Garberoglio C; De León D
    Growth Horm IGF Res; 2010 Apr; 20(2):162-70. PubMed ID: 20089431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of insulin-like growth factor-I receptor and insulin receptor substrate-1 expression in advanced human breast cancer.
    Schnarr B; Strunz K; Ohsam J; Benner A; Wacker J; Mayer D
    Int J Cancer; 2000 Nov; 89(6):506-13. PubMed ID: 11102895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of breast cancer-associated genes between stage- and age-matched tumor specimens from African- and Caucasian-American Women diagnosed with breast cancer.
    Grunda JM; Steg AD; He Q; Steciuk MR; Byan-Parker S; Johnson MR; Grizzle WE
    BMC Res Notes; 2012 May; 5():248. PubMed ID: 22616718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum insulin-like growth factor (IGF)-I and IGF binding protein-3 in relation to terminal duct lobular unit involution of the normal breast in Caucasian and African American women: The Susan G. Komen Tissue Bank.
    Oh H; Pfeiffer RM; Falk RT; Horne HN; Xiang J; Pollak M; Brinton LA; Storniolo AMV; Sherman ME; Gierach GL; Figueroa JD
    Int J Cancer; 2018 Aug; 143(3):496-507. PubMed ID: 29473153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factors in human breast cancer.
    Ellis MJ; Jenkins S; Hanfelt J; Redington ME; Taylor M; Leek R; Siddle K; Harris A
    Breast Cancer Res Treat; 1998; 52(1-3):175-84. PubMed ID: 10066081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of 12-gene colon cancer assay gene expression in African American and Caucasian patients with stage II colon cancer.
    Govindarajan R; Posey J; Chao CY; Lu R; Jadhav T; Javed AY; Javed A; Mahmoud FA; Osarogiagbon RU; Manne U
    BMC Cancer; 2016 Jun; 16():368. PubMed ID: 27316467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated Resistin Gene Expression in African American Estrogen and Progesterone Receptor Negative Breast Cancer.
    Vallega KA; Liu N; Myers JS; Yu K; Sang QX
    PLoS One; 2016; 11(6):e0157741. PubMed ID: 27314854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative determination of insulin-like growth factor 1 receptor mRNA in formalin-fixed paraffin-embedded tissues of invasive breast cancer.
    Fu P; Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Zheng S; Iwase H
    Breast Cancer; 2012 Oct; 19(4):321-8. PubMed ID: 21990036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High IGF1R protein expression correlates with disease-free survival of patients with stage III colon cancer.
    Zaanan A; Calmel C; Henriques J; Svrcek M; Blons H; Desbois-Mouthon C; Merabtene F; Goumard C; Parc Y; Gayet B; Taieb J; Validire P; Louvet C; Fléjou JF; Le Bouc Y; Praz F
    Cell Oncol (Dordr); 2020 Apr; 43(2):237-247. PubMed ID: 31823290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin.
    Zhang H; Pelzer AM; Kiang DT; Yee D
    Cancer Res; 2007 Jan; 67(1):391-7. PubMed ID: 17210722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic significance of the insulin-like growth factor-1 ligand and receptor expression in breast cancer tissue.
    Chong KY; Subramanian A; Mokbel K; Sharma AK
    J Surg Oncol; 2011 Sep; 104(3):228-35. PubMed ID: 21480260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotypes and haplotypes in the insulin-like growth factors, their receptors and binding proteins in relation to plasma metabolic levels and mammographic density.
    Biong M; Gram IT; Brill I; Johansen F; Solvang HK; Alnaes GI; Fagerheim T; Bremnes Y; Chanock SJ; Burdett L; Yeager M; Ursin G; Kristensen VN
    BMC Med Genomics; 2010 Mar; 3():9. PubMed ID: 20302654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds.
    Ludwig T; Eggenschwiler J; Fisher P; D'Ercole AJ; Davenport ML; Efstratiadis A
    Dev Biol; 1996 Aug; 177(2):517-35. PubMed ID: 8806828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentially expressed transcripts and dysregulated signaling pathways and networks in African American breast cancer.
    Stewart PA; Luks J; Roycik MD; Sang QX; Zhang J
    PLoS One; 2013; 8(12):e82460. PubMed ID: 24324792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of insulin-like growth factor 2 receptor and insulin-like growth factor binding proteins to identify control mechanisms for insulin-like growth factor 1 receptor phosphorylation.
    Tian D; Mitchell I; Kreeger PK
    BMC Syst Biol; 2016 Feb; 10():15. PubMed ID: 26861122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced immortalization, HUWE1 mutations and other biological drivers of breast invasive carcinoma in Black/African American patients.
    Andey T; Attah MM; Akwaaba-Reynolds NA; Cheema S; Parvin-Nejad S; Acquaah-Mensah GK
    Gene; 2020 Dec; 763S():100030. PubMed ID: 34493366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGF2R genetic variants, circulating IGF2 concentrations and colon cancer risk in African Americans and Whites.
    Hoyo C; Murphy SK; Schildkraut JM; Vidal AC; Skaar D; Millikan RC; Galanko J; Sandler RS; Jirtle R; Keku T
    Dis Markers; 2012; 32(2):133-41. PubMed ID: 22377707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistin and interleukin-6 exhibit racially-disparate expression in breast cancer patients, display molecular association and promote growth and aggressiveness of tumor cells through STAT3 activation.
    Deshmukh SK; Srivastava SK; Bhardwaj A; Singh AP; Tyagi N; Marimuthu S; Dyess DL; Dal Zotto V; Carter JE; Singh S
    Oncotarget; 2015 May; 6(13):11231-41. PubMed ID: 25868978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Race-associated biological differences among Luminal A breast tumors.
    D'Arcy M; Fleming J; Robinson WR; Kirk EL; Perou CM; Troester MA
    Breast Cancer Res Treat; 2015 Jul; 152(2):437-48. PubMed ID: 26109344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.